Course contents

TrichoTest™ – From Basics to Advanced
Interpretation

Prescribers
Pharmacists

Genetics, Trichology

This advanced course provides a comprehensive framework for interpreting TrichoTest™ reports and translating genetic data into precise therapeutic decisions. Participants will explore the scientific rationale behind the test, including SNP panel validation and pharmacogenetic associations related to androgenetic alopecia and treatment response. The course guides learners through report structure, API selection logic, and the clinical relevance of key genetic pathways such as prostaglandin signaling, androgen metabolism (SRD5A1/SRD5A2), sulfotransferase activity (SULT1A1), ACE-related vasodilation, IGF-1 signaling, inflammation, and micronutrient deficiencies. Special emphasis is placed on correlating genetics with drug response to minoxidil, finasteride, dutasteride, spironolactone, latanoprost, cetirizine, and other targeted treatments. The course also integrates questionnaire data, contraindications, and clinical blockers such as pregnancy, antihypertensive use, testosterone therapy, or alopecia areata diagnosis, to refine personalized prescribing strategies. By the end, participants will confidently interpret reports and design individualized, evidence-based hair loss protocols.
 English only
  Prescribers (target audience), Pharmacists
Write your awesome label here.
Write your awesome label here.
Compounding tips? Visit our

Formulary
A global hub for compounding knowledge and formulation guidance.

Minoxidil 1 to 7% in TrichoSol™

Hair solution

Dutasteride 0.25% and Minoxidil 5% in TrichoSol™

Hair solution

Finasteride 0.025% and Minoxidil 5% in TrichoSol™

Hair solution

Why should I take this course?

  • Master the interpretation of TrichoTest™ reports and understand the genetic basis behind treatment response variability
  • Learn how to select the most appropriate APIs based on SNP patterns, pharmacogenetics, and clinical context
  • Enhance your ability to deliver truly personalized alopecia treatments by integrating genetics, questionnaire data, and contraindications into decision-making

Course Lessons

Meet your instructor

Dr. Gustavo Torres de Souza

Dr Torres graduated as a pharmacist at UFJF and Colorado College and developed his Master's and PhD research on the state-of-the-art molecular biology techniques of genome editing, i.e.: CRISPR-Cas9 and TALENs in a partnership between EMBRAPA (Brazil) and Recombinetics (USA).
In graduate school, as part of the program of Genetics and Biotechnology, he worked in the Brazilian Agricultural Research Corporation, in collaboration with several private international entities. There he researched mechanisms involved in the use of lentivirus and CRISPR-Cas9 as systems to produce genetically modified animals for purposes including the production of human recombinant proteins for medical purposes, and improving the understanding phenotype-genotype relationships.
He also served as Assistant Professor at Paulista University, where he was responsible for teaching Human Genetics and Clinical Biochemistry, and currently serves as Project Manager in Fagron Genomics, Spain, coordinating the development of genetic tests, mainly focusing on pharmacogenetics.

Enjoyed this content? You may also like these ones: